119 related articles for article (PubMed ID: 28179584)
1. Novel neurobiological roles of UBE3A.
Sun J; Baudry M; Bi X
Oncotarget; 2017 Feb; 8(8):12548-12549. PubMed ID: 28179584
[No Abstract] [Full Text] [Related]
2. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
3. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
Sun J; Liu Y; Zhu G; Cato C; Hao X; Qian L; Lin W; Adhikari R; Luo Y; Baudry M; Bi X
Sci Rep; 2020 Jun; 10(1):9824. PubMed ID: 32555345
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.
Sun J; Liu Y; Moreno S; Baudry M; Bi X
J Neurosci; 2015 Mar; 35(11):4706-18. PubMed ID: 25788687
[TBL] [Abstract][Full Text] [Related]
5. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.
Talos DM; Jacobs LM; Gourmaud S; Coto CA; Sun H; Lim KC; Lucas TH; Davis KA; Martinez-Lage M; Jensen FE
Ann Neurol; 2018 Feb; 83(2):311-327. PubMed ID: 29331082
[TBL] [Abstract][Full Text] [Related]
8. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
9. mTOR takes charge: Relaying uncharged tRNA levels by mTOR ubiquitination.
Jacinto E
Cell Metab; 2023 Dec; 35(12):2097-2099. PubMed ID: 38056426
[TBL] [Abstract][Full Text] [Related]
10. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
Godavarthi SK; Dey P; Maheshwari M; Jana NR
Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Reiter LT; Seagroves TN; Bowers M; Bier E
Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
[TBL] [Abstract][Full Text] [Related]
12. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
[TBL] [Abstract][Full Text] [Related]
13. The picky mTORC1 in metabolic enzyme degradation.
Chun Y; Fruman DA; Lee G
Mol Cell; 2024 Jun; 84(11):2011-2013. PubMed ID: 38848689
[TBL] [Abstract][Full Text] [Related]
14. A systems study reveals concurrent activation of AMPK and mTOR by amino acids.
Dalle Pezze P; Ruf S; Sonntag AG; Langelaar-Makkinje M; Hall P; Heberle AM; Razquin Navas P; van Eunen K; Tölle RC; Schwarz JJ; Wiese H; Warscheid B; Deitersen J; Stork B; Fäßler E; Schäuble S; Hahn U; Horvatovich P; Shanley DP; Thedieck K
Nat Commun; 2016 Nov; 7():13254. PubMed ID: 27869123
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?
Magdalon J; Sánchez-Sánchez SM; Griesi-Oliveira K; Sertié AL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335463
[TBL] [Abstract][Full Text] [Related]
16. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
[TBL] [Abstract][Full Text] [Related]
17. Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders.
Xu X; Li C; Gao X; Xia K; Guo H; Li Y; Hao Z; Zhang L; Gao D; Xu C; Xu H; Xiong ZQ; Qiu Z; Mei L; Xie X; Ruan K; Hu R
Cell Res; 2018 Jan; 28(1):48-68. PubMed ID: 29076503
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.
Rogers-Broadway KR; Kumar J; Sisu C; Wander G; Mazey E; Jeyaneethi J; Pados G; Tsolakidis D; Klonos E; Grunt T; Hall M; Chatterjee J; Karteris E
Int J Mol Med; 2019 Jan; 43(1):47-56. PubMed ID: 30387804
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
Brown AL; Fluitt MB; Ecelbarger CM
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
